Logo

Predicant Biosciences Obtains $7.5M Debt Financing to Develop Protein Biomarker Technology

Oct 11, 2005

NEW YORK, Oct. 11 (GenomeWeb News) - Predicant Biosciences has received $7.5 million in debt financing from Hercules Technology Growth Capital, the Palo Alto-based specialty finance company said today.

 

Predicant will use the financing to develop and market protein biomarker technology for diagnostic tests.

 

The company, based in South San Francisco, Calif., has been developing separation, detection, and informatics technologies for identifying and assaying protein biomarkers for use in diagnostics and drug development.

Breaking News
The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.